Chong Kun Dang Pharmaceutical Corp.

KRX:185750.KS

92100 (KRW) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 412,762.304396,802.359353,450504,611.048403,606.493396,005.766365,181.132397,057.679383,889.44366,025.753341,371.857361,871.659342,238.862327,535.685311,913.156337,226.433358,390.808314,027.482293,360.802298,185.681280,582.24266,560.648234,009.092265,234.651235,105.767237,338.043218,540.427243,997.582219,657.972211,008.295209,698.960204,675.627205,687.938201,946.66155,492.201149,686.108140,023.504147,291.66141,212.395127,285.067136,951.216138,681.082
Cost of Revenue 283,933.402257,874.695230,774.948273,761.39253,782.249251,656.479229,703.992254,635.043243,526.946231,466.784216,076.563237,454.904213,596.483197,758.322198,931.371207,282.598223,191.575194,084.126189,307.406185,855.365178,172.96164,871.777146,159.006163,123.349138,896.724140,685.858133,109.647144,075.814128,657.219126,652.414125,321.0150119,240.085119,874.686120,005.97877,837.95672,488.62567,793.55278,192.01767,903.97163,064.31461,453.01771,367.235
Gross Profit 128,828.902138,927.663122,675.052230,849.658149,824.244144,349.287135,477.14142,422.635140,362.494134,558.969125,295.294124,416.756128,642.379129,777.364112,981.785129,943.835135,199.232119,943.356104,053.396112,330.316102,409.28101,688.87187,850.086102,111.30296,209.04396,652.18585,430.7899,921.76891,000.75384,355.88184,377.945085,435.54285,813.25281,940.68277,654.24577,197.48372,229.95269,099.64373,308.42464,220.75375,498.19967,313.847
Gross Profit Ratio 0.3120.350.3470.4570.3710.3650.3710.3590.3660.3680.3670.3440.3760.3960.3620.3850.3770.3820.3550.3770.3650.3810.3750.3850.4090.4070.3910.410.4140.40.40200.4170.4170.4060.4990.5160.5160.4690.5190.5050.5510.485
Reseach & Development Expenses 033,138.56129,664.62345,764.25427,061.03531,580.85735,828.39660,149.57438,206.21241,211.15136,757.9450,899.46934,513.88639,963.27737,900.0858,426.44932,088.48231,535.96724,613.0832,970.41122,226.67324,188.2519,238.31623,519.96319,238.90818,721.10415,554.49719,583.8314,717.67614,846.3615,903.92014,663.31118,535.15718,934.95819,304.01114,918.40513,530.35510,002.16616,060.5998,718.9949,195.2488,894.077
General & Administrative Expenses 102,804.399104,851.645101,697.7036,435.8494,090.22399,349.7436,374.965,508.6265,801.4255,685.7145,567.7235,168.0975,004.9815,064.1754,998.0884,331.2644,834.4074,422.2774,292.3235,468.1925,637.746,052.1984,741.27113,648.8385,542.8095,679.9895,554.0846,745.16,223.2056,573.2976,782.87506,909.4668,694.2597,434.5885,486.9038,106.1927,041.9217,433.3236,513.5794,705.8855,228.4646,508.006
Selling & Marketing Expenses 0-37,974.976-35,257.427,434.88625,993.30927,549.3925,405.21724,090.55323,118.9325,106.61421,571.47225,408.71818,216.45521,071.66917,781.72521,617.30118,272.51217,903.46715,695.79719,265.26118,400.23520,273.32218,890.99325,060.33120,701.10122,575.08618,395.77323,777.52318,199.26617,208.4818,270.265015,890.76119,773.49820,784.46916,739.03217,236.9517,939.83614,594.28717,673.07114,285.20319,494.02915,343.345
SG&A 102,804.39966,876.66966,440.30367,948.56594,090.22399,349.74331,780.17729,599.17928,920.35530,792.32827,139.19530,576.81523,221.43626,135.84422,779.81325,948.56523,106.91922,325.74419,988.1224,733.45324,037.97526,325.5223,632.26438,709.16926,243.9128,255.07523,949.85730,522.62324,422.47123,781.77725,053.14022,800.22728,467.75728,219.05722,225.93525,343.14224,981.75722,027.6124,186.6518,991.08824,722.49321,851.351
Other Expenses -0.00135,622.289-326,696-2,741.469-188,180.446-198,699.48636,376.30734,081.26933,914.1835,615.636,346.349455.751-10,922.651637.282562.571271.962557.599689.555380.7431,247.521427.624403.082424.695918.34392.131536.497-5,531.196-227.015447.962352.123238.7350366.881457.502307.48316.38699.016-20,173.817-2,634.756-1,247.232308.341232.9518.28
Operating Expenses 102,804.398103,065.988326,696116,454.288-94,090.223-99,349.743103,984.88123,830.022101,040.747107,619.079100,243.484119,346.77692,471.66998,134.54391,106.602116,589.99486,845.78983,573.25578,194.90291,472.45382,834.11583,452.44371,943.93283,682.55575,778.18478,573.15866,629.52278,977.5967,274.62268,022.69367,616.448063,192.41575,238.85273,684.5667,102.25465,410.45764,121.98856,841.53965,038.28251,205.37458,092.19752,075.146
Operating Income 26,024.50440,676.17626,754114,395.3755,734.02144,999.54431,492.25918,592.61539,321.74626,939.8925,051.815,069.98136,170.71131,642.82121,875.18213,353.84248,353.44336,370.125,858.49420,857.86419,575.16518,236.42915,906.15518,428.74820,430.85918,079.02818,801.25920,944.17623,726.13116,333.18816,761.497022,243.12610,574.48,256.12210,551.99111,787.0268,107.96512,258.1058,270.14213,015.37917,406.00215,238.701
Operating Income Ratio 0.0630.1030.0760.2270.1380.1140.0860.0470.1020.0740.0730.0140.1060.0970.070.040.1350.1160.0880.070.070.0680.0680.0690.0870.0760.0860.0860.1080.0770.0800.1090.0510.0410.0680.0790.0580.0830.0590.1020.1270.11
Total Other Income Expenses Net 519.584-2,013.6042,525.514-4,135.225-462.548-419.429-5,039.138-6,217.609-2,549.276-2,871.153-1,102.956-955.635-11,530.493-3,359.51-2,092.98315.118-1,347.705-2,758.18-1,658.327-1,207.778-458.497-338.813-4,249.929111.217-1,198.824-2,486.199-6,542.059-859.622-708.821-738.724-876.140-1,537.086-339.481-531.357-3,129.028189.553-21,284.712-3,343.253-2,506.651-1,050.19-883.541-1,007.695
Income Before Tax 26,544.08838,662.57231,795110,238.2355,271.47344,580.11531,508.0312,375.00636,772.4724,068.73723,948.8544,114.34624,640.21832,032.83319,806.45713,368.9647,029.99737,215.57624,224.42519,650.08719,140.92717,897.61615,132.54818,539.96519,232.03518,309.14812,259.220,102.0323,017.3115,594.46415,885.357020,706.0410,234.9197,724.7657,422.96311,976.579-13,176.7478,914.8525,763.49111,965.18916,522.46114,231.006
Income Before Tax Ratio 0.0640.0970.090.2180.1370.1130.0860.0310.0960.0660.070.0110.0720.0980.0630.040.1310.1190.0830.0660.0680.0670.0650.070.0820.0770.0560.0820.1050.0740.07600.1010.050.0380.0480.08-0.0940.0610.0410.0940.1210.103
Income Tax Expense 4,876.742-16,377.2686,69822,123.0679,033.941,416.887-4,578.233642.238,563.611,523.626,457.8281,516.97822,912.4658,736.6215,071.3172,783.93212,429.259,322.8046,898.0813,879.274,934.6885,466.6664,565.2675,474.5195,844.6295,762.4839,554.3125,603.2596,444.5624,372.5334,450.55205,797.8322,931.3322,162.5772,271.63,594.63613,238.5232,805.632,119.5382,732.5485,086.4263,389.893
Net Income 21,847.87253,363.33625,573.57488,253.90445,596.74542,818.50135,852.02111,829.79428,544.47423,154.49617,424.5981,568.0652,144.88423,958.79715,048.63411,166.93434,941.27327,635.5617,888.99215,849.82814,514.71112,662.06710,855.0413,294.68613,566.43712,705.762,831.65214,577.71916,572.74811,221.9311,434.805014,908.2087,303.5875,562.1885,151.3648,381.943-26,415.2696,109.2223,643.9539,232.6411,436.03510,841.113
Net Income Ratio 0.0530.1340.0720.1750.1130.1080.0980.030.0740.0630.0510.0040.0060.0730.0480.0330.0970.0880.0610.0530.0520.0480.0460.050.0580.0540.0130.060.0750.0530.05500.0730.0360.0280.0330.056-0.1890.0410.0260.0730.0840.078
EPS 1,729.944,207.61,972.626,935.423,575.973,355.232,807.01924.322,336.241,883.311,413.28208.98164.171,830.391,147.39982.992,659.762,103.441,361.411,394.681,103.24962.56825.171,169.371,031.12965.3215.471,214.311,252.15848.45864.121,333.331,182.75579.81441.01450.68664.88-2,096.12485.04318.8732.78907.4860.39
EPS Diluted 1,729.944,207.61,972.626,935.423,575.973,355.232,807.01924.322,336.241,883.311,413.28208.98164.171,830.391,147.39982.992,659.762,103.441,361.411,394.681,103.24962.56825.171,169.371,031.12965.3215.471,214.311,252.15848.45864.121,333.331,182.75579.81441.01450.68664.88-2,096.12485.04318.8732.78907.4860.39
EBITDA 128,828.90250,175.02540,202.455121,747.95667,050.55956,317.30943,376.94123,340.74547,029.84934,222.03233,389.75813,574.10843,054.59139,655.05628,244.04220,613.27953,653.4541,856.92731,597.79128,035.98824,799.83723,545.77721,246.45423,764.2125,784.13623,414.83423,994.7326,189.85729,033.77621,980.60622,546.101028,664.3817,398.56314,414.61416,656.35918,718.989-6,475.70615,589.66212,252.00918,445.66723,021.45520,678.058
EBITDA Ratio 0.3120.1260.0760.2450.3710.3650.1160.0710.1250.0960.0980.0350.0960.1190.0910.0610.150.140.1090.0970.0910.0910.0930.0940.110.1010.0860.1070.1330.1040.10800.140.0850.0710.1070.125-0.0460.1060.0870.1450.1680.149